Sanofi | SNY - Денежные средства и эквиваленты

Биржевая цена
46.75
Изменение за день
0.73 1.59%
Ежемесячно
-3.05%
Ежегодный
-13.63%
Q2 прогноз
45.74




Денежные средства и эквиваленты Изменить Дата
AbbVie USD 5.23B 400M 2025-12
Amgen USD 9.13B 316M 2025-12
AstraZeneca USD 7.56B 1.85B 2026-03
Bristol-Myers Squibb USD 9.57B 635M 2026-03
Canopy Growth CAD 371.32M 73.26M 2025-12
Corcept Therapeutics USD 120.49M 4.64M 2025-12
Drreddys Laboratories INR 18.66B 9.65B 2025-12
Eli Lilly USD 5.28B 1.99B 2026-03
Galapagos EUR 87.87M 23.41M 2025-12
Genmab DKK 1.72B 46M 2025-12
GlaxoSmithKline GBP 3.44B 292M 2026-03
Glaxosmithkline GBP 3.3B 303M 2025-09
J&J USD 21.69B 1.98B 2026-03
Merck USD 14.57B 3.6B 2025-12
Novartis USD 11.44B 1.88B 2025-12
Novartis USD 9.56B 2.9B 2025-09
Pacira USD 158.54M 10.96M 2025-12
Perrigo USD 432.1M 22.1M 2025-09
Pfizer USD 1.34B 295M 2025-09
Phibro Animal Health USD 55.49M 17.28M 2025-12
Prestige Brands USD 62.37M 56.73M 2025-12
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 7.66B 1.25B 2025-12
Sanofi EUR 7.66B 1.25B 2025-12
Supernus Pharmaceuticals USD 151.37M 6.66M 2025-09
UCB EUR 1.57B 1.14B 2024-12
Zoetis USD 2.08B 649M 2025-09